Patent · US Active

Meglumine salts of thienopyrimidines

US10822346B2 · kind B2 · utility

0Cited by
6References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 16, 2019
Grant dateNov 3, 2020
Priority date—
Expiry dateApr 16, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Disclosed herein are thienopyrimidine meglumine salts according to Formula (I) used for treating or preventing heart failure:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.